Zavesca 100 mg/1
miglustat · CAPSULE · Actelion Pharmaceuticals US, Inc.
No Recall History
Plain English
Zavesca is a capsule containing miglustat at 100 mg/1, taken oral. Manufactured by Actelion Pharmaceuticals US, Inc..
Key Facts
- Brand Name
- Zavesca
- Generic Name
- miglustat
- NDC Code (Product)
66215-201- Manufacturer
- Actelion Pharmaceuticals US, Inc.
- Strength
- 100 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA021348
- Drug Class
- Glucosylceramide Synthase Inhibitor [EPC]; Enzyme Stabilizer [EPC]
- Marketing Start
- 07/31/2003
Recall History
No Recall HistoryFrequently Asked Questions
What is Zavesca used for?
Zavesca contains miglustat. It is a capsule taken oral. Consult your doctor for specific uses.
Is Zavesca a controlled substance?
Zavesca is not classified as a controlled substance by the DEA.
What is the generic name for Zavesca?
The generic name for Zavesca is miglustat. There are 6 other brand versions of miglustat.
What is the NDC code for Zavesca 100 mg/1?
The NDC (National Drug Code) for Zavesca 100 mg/1 is 66215-201, listed by Actelion Pharmaceuticals US, Inc..